glp-1 discontinuation Many adults stop therapy within a year with low restart rates, analysis finds Fractyl Health Announces Groundbreaking Data

Mechanisms Linking COVID-19 to Post-Infectious IBS Given the known enteropathic effects of SARS-CoV-2 and the psychological stress induced by the pandemic, it is possible that the prevalence of DGBI increased during this period. Neurogastroenterology & Motility Study Investigators , Authors of a large-scale, peer-reviewed epidemiological study on GI disorders during COVID-19 Several complex pathophysiological mechanisms underpin the development of post-infectious IBS following COVID-19 infection

Am J Surg Pathol 1:131143 Ashida A, Takata M, Murata H, Kido K, Saida T (2009) Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas

Its choosing foods that support digestion, nutrient intake, and sustainable weight loss

Selenium Antagonism with Mercury and Arsenic: From Chemistry to Population Health and Demography

Beyond Diabetes and Weight Loss The Growing Demand for GLP-1 Therapies In 2023, over 174,000 people in the United States were prescribed GLP-1RAs, a rise of over 700% from 2019, when about 21,000 individuals were prescribed this medication